BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Catabasis Pharmaceuticals, Inc. 

161 First Street, Suite 1A

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-349-1971 Fax: 617-273-2637


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Catabasis Pharmaceuticals, Inc. To Present CAT-2003 Data At The American College of Cardiology’s 63rd Annual Scientific Session 3/31/2014 6:44:41 AM    More...
Catabasis Pharmaceuticals, Inc. To Present Data On CAT-1004 At The Muscular Dystrophy Association's 2014 Clinical Conference 3/14/2014 6:38:04 AM    More...
Catabasis Pharmaceuticals, Inc. Names Andrew Nichols, Ph.D., Vice President Of Research 2/26/2014 6:38:09 AM    More...
Catabasis Pharmaceuticals, Inc. Announces Appointment Of Kenneth M. Bate As Independent Director 2/4/2014 7:19:55 AM    More...
Catabasis Pharmaceuticals, Inc. To Present At 32nd Annual J.P. Morgan Healthcare Conference 1/8/2014 7:13:46 AM    More...
Catabasis Pharmaceuticals, Inc. Initiates Phase 2 Trial Of CAT-2003 In Patients With Severe Hypertriglyceridemia 12/5/2013 11:32:18 AM    More...
Catabasis Pharmaceuticals, Inc. Seizes $32.4 Million Series B Financing With IPO In Sight 11/15/2013 7:09:30 AM    More...
Catabasis Pharmaceuticals, Inc. Names Ian Sanderson Chief Financial Officer 11/13/2013 9:58:43 AM    More...
Catabasis Pharmaceuticals, Inc. to Present Phase 1 Data From Oral SMART Linker Conjugate CAT-2003 at Upcoming Conference 8/28/2013 10:01:57 AM    More...
Catabasis Pharmaceuticals, Inc. Initiates Phase 2 Trial of CAT-2003 in Patients With Hypertriglyceridemia and Hypercholesterolemia 8/21/2013 8:53:14 AM    More...
123

//-->